Global Parkinson Disease Drug Market Insights and Forecast to 2031

Report ID: 1549504 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Parkinson Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Sinemet-CR
        1.2.3 Trastal
        1.2.4 Madopar
        1.2.5 COMT Inhibitor
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Parkinson Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Under 40 Years Old
        1.3.3 40-65 Years Old
        1.3.4 Above 65 Years Old
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Parkinson Disease Drug Market Perspective (2017-2028)
    2.2 Parkinson Disease Drug Growth Trends by Region
        2.2.1 Parkinson Disease Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Parkinson Disease Drug Historic Market Size by Region (2017-2022)
        2.2.3 Parkinson Disease Drug Forecasted Market Size by Region (2023-2028)
    2.3 Parkinson Disease Drug Market Dynamics
        2.3.1 Parkinson Disease Drug Industry Trends
        2.3.2 Parkinson Disease Drug Market Drivers
        2.3.3 Parkinson Disease Drug Market Challenges
        2.3.4 Parkinson Disease Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Parkinson Disease Drug Players by Revenue
        3.1.1 Global Top Parkinson Disease Drug Players by Revenue (2017-2022)
        3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Parkinson Disease Drug Revenue
    3.4 Global Parkinson Disease Drug Market Concentration Ratio
        3.4.1 Global Parkinson Disease Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Parkinson Disease Drug Revenue in 2021
    3.5 Parkinson Disease Drug Key Players Head office and Area Served
    3.6 Key Players Parkinson Disease Drug Product Solution and Service
    3.7 Date of Enter into Parkinson Disease Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson Disease Drug Breakdown Data by Type
    4.1 Global Parkinson Disease Drug Historic Market Size by Type (2017-2022)
    4.2 Global Parkinson Disease Drug Forecasted Market Size by Type (2023-2028)
5 Parkinson Disease Drug Breakdown Data by Application
    5.1 Global Parkinson Disease Drug Historic Market Size by Application (2017-2022)
    5.2 Global Parkinson Disease Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Parkinson Disease Drug Market Size (2017-2028)
    6.2 North America Parkinson Disease Drug Market Size by Type
        6.2.1 North America Parkinson Disease Drug Market Size by Type (2017-2022)
        6.2.2 North America Parkinson Disease Drug Market Size by Type (2023-2028)
        6.2.3 North America Parkinson Disease Drug Market Share by Type (2017-2028)
    6.3 North America Parkinson Disease Drug Market Size by Application
        6.3.1 North America Parkinson Disease Drug Market Size by Application (2017-2022)
        6.3.2 North America Parkinson Disease Drug Market Size by Application (2023-2028)
        6.3.3 North America Parkinson Disease Drug Market Share by Application (2017-2028)
    6.4 North America Parkinson Disease Drug Market Size by Country
        6.4.1 North America Parkinson Disease Drug Market Size by Country (2017-2022)
        6.4.2 North America Parkinson Disease Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Parkinson Disease Drug Market Size (2017-2028)
    7.2 Europe Parkinson Disease Drug Market Size by Type
        7.2.1 Europe Parkinson Disease Drug Market Size by Type (2017-2022)
        7.2.2 Europe Parkinson Disease Drug Market Size by Type (2023-2028)
        7.2.3 Europe Parkinson Disease Drug Market Share by Type (2017-2028)
    7.3 Europe Parkinson Disease Drug Market Size by Application
        7.3.1 Europe Parkinson Disease Drug Market Size by Application (2017-2022)
        7.3.2 Europe Parkinson Disease Drug Market Size by Application (2023-2028)
        7.3.3 Europe Parkinson Disease Drug Market Share by Application (2017-2028)
    7.4 Europe Parkinson Disease Drug Market Size by Country
        7.4.1 Europe Parkinson Disease Drug Market Size by Country (2017-2022)
        7.4.2 Europe Parkinson Disease Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Parkinson Disease Drug Market Size (2017-2028)
    8.2 Asia-Pacific Parkinson Disease Drug Market Size by Type
        8.2.1 Asia-Pacific Parkinson Disease Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Parkinson Disease Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Parkinson Disease Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Parkinson Disease Drug Market Size by Application
        8.3.1 Asia-Pacific Parkinson Disease Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Parkinson Disease Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Parkinson Disease Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Parkinson Disease Drug Market Size by Region
        8.4.1 Asia-Pacific Parkinson Disease Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Parkinson Disease Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Parkinson Disease Drug Market Size (2017-2028)
    9.2 Latin America Parkinson Disease Drug Market Size by Type
        9.2.1 Latin America Parkinson Disease Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Parkinson Disease Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Parkinson Disease Drug Market Share by Type (2017-2028)
    9.3 Latin America Parkinson Disease Drug Market Size by Application
        9.3.1 Latin America Parkinson Disease Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Parkinson Disease Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Parkinson Disease Drug Market Share by Application (2017-2028)
    9.4 Latin America Parkinson Disease Drug Market Size by Country
        9.4.1 Latin America Parkinson Disease Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Parkinson Disease Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Parkinson Disease Drug Market Size (2017-2028)
    10.2 Middle East & Africa Parkinson Disease Drug Market Size by Type
        10.2.1 Middle East & Africa Parkinson Disease Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Parkinson Disease Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Parkinson Disease Drug Market Size by Application
        10.3.1 Middle East & Africa Parkinson Disease Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Parkinson Disease Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Parkinson Disease Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Parkinson Disease Drug Market Size by Country
        10.4.1 Middle East & Africa Parkinson Disease Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Parkinson Disease Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Details
        11.1.2 Merck Business Overview
        11.1.3 Merck Parkinson Disease Drug Introduction
        11.1.4 Merck Revenue in Parkinson Disease Drug Business (2017-2022)
        11.1.5 Merck Recent Developments
    11.2 Akorn
        11.2.1 Akorn Company Details
        11.2.2 Akorn Business Overview
        11.2.3 Akorn Parkinson Disease Drug Introduction
        11.2.4 Akorn Revenue in Parkinson Disease Drug Business (2017-2022)
        11.2.5 Akorn Recent Developments
    11.3 GSK
        11.3.1 GSK Company Details
        11.3.2 GSK Business Overview
        11.3.3 GSK Parkinson Disease Drug Introduction
        11.3.4 GSK Revenue in Parkinson Disease Drug Business (2017-2022)
        11.3.5 GSK Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Parkinson Disease Drug Introduction
        11.4.4 Novartis Revenue in Parkinson Disease Drug Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Parkinson Disease Drug Introduction
        11.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2017-2022)
        11.5.5 Boehringer Ingelheim Recent Developments
    11.6 Teva Pharmaceutical
        11.6.1 Teva Pharmaceutical Company Details
        11.6.2 Teva Pharmaceutical Business Overview
        11.6.3 Teva Pharmaceutical Parkinson Disease Drug Introduction
        11.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2017-2022)
        11.6.5 Teva Pharmaceutical Recent Developments
    11.7 Abbvie
        11.7.1 Abbvie Company Details
        11.7.2 Abbvie Business Overview
        11.7.3 Abbvie Parkinson Disease Drug Introduction
        11.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2017-2022)
        11.7.5 Abbvie Recent Developments
    11.8 Kyowa Hakko Kirin Pharma
        11.8.1 Kyowa Hakko Kirin Pharma Company Details
        11.8.2 Kyowa Hakko Kirin Pharma Business Overview
        11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Introduction
        11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2017-2022)
        11.8.5 Kyowa Hakko Kirin Pharma Recent Developments
    11.9 Astellas Pharma
        11.9.1 Astellas Pharma Company Details
        11.9.2 Astellas Pharma Business Overview
        11.9.3 Astellas Pharma Parkinson Disease Drug Introduction
        11.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2017-2022)
        11.9.5 Astellas Pharma Recent Developments
    11.10 Desitin Arzneimittel
        11.10.1 Desitin Arzneimittel Company Details
        11.10.2 Desitin Arzneimittel Business Overview
        11.10.3 Desitin Arzneimittel Parkinson Disease Drug Introduction
        11.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2017-2022)
        11.10.5 Desitin Arzneimittel Recent Developments
    11.11 Endo Pharmaceuticals
        11.11.1 Endo Pharmaceuticals Company Details
        11.11.2 Endo Pharmaceuticals Business Overview
        11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Introduction
        11.11.4 Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2017-2022)
        11.11.5 Endo Pharmaceuticals Recent Developments
    11.12 F.Hoffmann-La Roche
        11.12.1 F.Hoffmann-La Roche Company Details
        11.12.2 F.Hoffmann-La Roche Business Overview
        11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Introduction
        11.12.4 F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2017-2022)
        11.12.5 F.Hoffmann-La Roche Recent Developments
    11.13 H.Lundbeck
        11.13.1 H.Lundbeck Company Details
        11.13.2 H.Lundbeck Business Overview
        11.13.3 H.Lundbeck Parkinson Disease Drug Introduction
        11.13.4 H.Lundbeck Revenue in Parkinson Disease Drug Business (2017-2022)
        11.13.5 H.Lundbeck Recent Developments
    11.14 Valeant
        11.14.1 Valeant Company Details
        11.14.2 Valeant Business Overview
        11.14.3 Valeant Parkinson Disease Drug Introduction
        11.14.4 Valeant Revenue in Parkinson Disease Drug Business (2017-2022)
        11.14.5 Valeant Recent Developments
    11.15 Apokyn
        11.15.1 Apokyn Company Details
        11.15.2 Apokyn Business Overview
        11.15.3 Apokyn Parkinson Disease Drug Introduction
        11.15.4 Apokyn Revenue in Parkinson Disease Drug Business (2017-2022)
        11.15.5 Apokyn Recent Developments
    11.16 Orion
        11.16.1 Orion Company Details
        11.16.2 Orion Business Overview
        11.16.3 Orion Parkinson Disease Drug Introduction
        11.16.4 Orion Revenue in Parkinson Disease Drug Business (2017-2022)
        11.16.5 Orion Recent Developments
    11.17 Stada Arzneimittel
        11.17.1 Stada Arzneimittel Company Details
        11.17.2 Stada Arzneimittel Business Overview
        11.17.3 Stada Arzneimittel Parkinson Disease Drug Introduction
        11.17.4 Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2017-2022)
        11.17.5 Stada Arzneimittel Recent Developments
    11.18 US WorldMeds
        11.18.1 US WorldMeds Company Details
        11.18.2 US WorldMeds Business Overview
        11.18.3 US WorldMeds Parkinson Disease Drug Introduction
        11.18.4 US WorldMeds Revenue in Parkinson Disease Drug Business (2017-2022)
        11.18.5 US WorldMeds Recent Developments
    11.19 Bausch Health
        11.19.1 Bausch Health Company Details
        11.19.2 Bausch Health Business Overview
        11.19.3 Bausch Health Parkinson Disease Drug Introduction
        11.19.4 Bausch Health Revenue in Parkinson Disease Drug Business (2017-2022)
        11.19.5 Bausch Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Parkinson Disease Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Sinemet-CR
    Table 3. Key Players of Trastal
    Table 4. Key Players of Madopar
    Table 5. Key Players of COMT Inhibitor
    Table 6. Key Players of Other
    Table 7. Global Parkinson Disease Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Parkinson Disease Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Parkinson Disease Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Parkinson Disease Drug Market Share by Region (2017-2022)
    Table 11. Global Parkinson Disease Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Parkinson Disease Drug Market Share by Region (2023-2028)
    Table 13. Parkinson Disease Drug Market Trends
    Table 14. Parkinson Disease Drug Market Drivers
    Table 15. Parkinson Disease Drug Market Challenges
    Table 16. Parkinson Disease Drug Market Restraints
    Table 17. Global Parkinson Disease Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Parkinson Disease Drug Revenue Share by Players (2017-2022)
    Table 19. Global Top Parkinson Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2021)
    Table 20. Ranking of Global Top Parkinson Disease Drug Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Parkinson Disease Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Parkinson Disease Drug Product Solution and Service
    Table 24. Date of Enter into Parkinson Disease Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Parkinson Disease Drug Revenue Market Share by Type (2017-2022)
    Table 28. Global Parkinson Disease Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Parkinson Disease Drug Revenue Market Share by Type (2023-2028)
    Table 30. Global Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Parkinson Disease Drug Revenue Share by Application (2017-2022)
    Table 32. Global Parkinson Disease Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Parkinson Disease Drug Revenue Share by Application (2023-2028)
    Table 34. North America Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Parkinson Disease Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Parkinson Disease Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Parkinson Disease Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Parkinson Disease Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Parkinson Disease Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Parkinson Disease Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Parkinson Disease Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Parkinson Disease Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Parkinson Disease Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Parkinson Disease Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Merck Company Details
    Table 65. Merck Business Overview
    Table 66. Merck Parkinson Disease Drug Product
    Table 67. Merck Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 68. Merck Recent Developments
    Table 69. Akorn Company Details
    Table 70. Akorn Business Overview
    Table 71. Akorn Parkinson Disease Drug Product
    Table 72. Akorn Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 73. Akorn Recent Developments
    Table 74. GSK Company Details
    Table 75. GSK Business Overview
    Table 76. GSK Parkinson Disease Drug Product
    Table 77. GSK Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 78. GSK Recent Developments
    Table 79. Novartis Company Details
    Table 80. Novartis Business Overview
    Table 81. Novartis Parkinson Disease Drug Product
    Table 82. Novartis Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 83. Novartis Recent Developments
    Table 84. Boehringer Ingelheim Company Details
    Table 85. Boehringer Ingelheim Business Overview
    Table 86. Boehringer Ingelheim Parkinson Disease Drug Product
    Table 87. Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 88. Boehringer Ingelheim Recent Developments
    Table 89. Teva Pharmaceutical Company Details
    Table 90. Teva Pharmaceutical Business Overview
    Table 91. Teva Pharmaceutical Parkinson Disease Drug Product
    Table 92. Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 93. Teva Pharmaceutical Recent Developments
    Table 94. Abbvie Company Details
    Table 95. Abbvie Business Overview
    Table 96. Abbvie Parkinson Disease Drug Product
    Table 97. Abbvie Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 98. Abbvie Recent Developments
    Table 99. Kyowa Hakko Kirin Pharma Company Details
    Table 100. Kyowa Hakko Kirin Pharma Business Overview
    Table 101. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product
    Table 102. Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 103. Kyowa Hakko Kirin Pharma Recent Developments
    Table 104. Astellas Pharma Company Details
    Table 105. Astellas Pharma Business Overview
    Table 106. Astellas Pharma Parkinson Disease Drug Product
    Table 107. Astellas Pharma Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 108. Astellas Pharma Recent Developments
    Table 109. Desitin Arzneimittel Company Details
    Table 110. Desitin Arzneimittel Business Overview
    Table 111. Desitin Arzneimittel Parkinson Disease Drug Product
    Table 112. Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 113. Desitin Arzneimittel Recent Developments
    Table 114. Endo Pharmaceuticals Company Details
    Table 115. Endo Pharmaceuticals Business Overview
    Table 116. Endo Pharmaceuticals Parkinson Disease Drug Product
    Table 117. Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 118. Endo Pharmaceuticals Recent Developments
    Table 119. F.Hoffmann-La Roche Company Details
    Table 120. F.Hoffmann-La Roche Business Overview
    Table 121. F.Hoffmann-La Roche Parkinson Disease Drug Product
    Table 122. F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 123. F.Hoffmann-La Roche Recent Developments
    Table 124. H.Lundbeck Company Details
    Table 125. H.Lundbeck Business Overview
    Table 126. H.Lundbeck Parkinson Disease Drug Product
    Table 127. H.Lundbeck Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 128. H.Lundbeck Recent Developments
    Table 129. Valeant Company Details
    Table 130. Valeant Business Overview
    Table 131. Valeant Parkinson Disease Drug Product
    Table 132. Valeant Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 133. Valeant Recent Developments
    Table 134. Apokyn Company Details
    Table 135. Apokyn Business Overview
    Table 136. Apokyn Parkinson Disease Drug Product
    Table 137. Apokyn Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 138. Apokyn Recent Developments
    Table 139. Orion Company Details
    Table 140. Orion Business Overview
    Table 141. Orion Parkinson Disease Drug Product
    Table 142. Orion Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 143. Orion Recent Developments
    Table 144. Stada Arzneimittel Company Details
    Table 145. Stada Arzneimittel Business Overview
    Table 146. Stada Arzneimittel Parkinson Disease Drug Product
    Table 147. Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 148. Stada Arzneimittel Recent Developments
    Table 149. US WorldMeds Company Details
    Table 150. US WorldMeds Business Overview
    Table 151. US WorldMeds Parkinson Disease Drug Product
    Table 152. US WorldMeds Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 153. US WorldMeds Recent Developments
    Table 154. Bausch Health Company Details
    Table 155. Bausch Health Business Overview
    Table 156. Bausch Health Parkinson Disease Drug Product
    Table 157. Bausch Health Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
    Table 158. Bausch Health Recent Developments
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parkinson Disease Drug Market Share by Type: 2021 VS 2028
    Figure 2. Sinemet-CR Features
    Figure 3. Trastal Features
    Figure 4. Madopar Features
    Figure 5. COMT Inhibitor Features
    Figure 6. Other Features
    Figure 7. Global Parkinson Disease Drug Market Share by Application: 2021 VS 2028
    Figure 8. Under 40 Years Old Case Studies
    Figure 9. 40-65 Years Old Case Studies
    Figure 10. Above 65 Years Old Case Studies
    Figure 11. Parkinson Disease Drug Report Years Considered
    Figure 12. Global Parkinson Disease Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Parkinson Disease Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Parkinson Disease Drug Market Share by Region: 2021 VS 2028
    Figure 15. Global Parkinson Disease Drug Market Share by Players in 2021
    Figure 16. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Parkinson Disease Drug Revenue in 2021
    Figure 18. North America Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
    Figure 20. North America Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
    Figure 21. North America Parkinson Disease Drug Market Size Share by Country (2017-2028)
    Figure 22. United States Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Parkinson Disease Drug Market Size Share by Country (2017-2028)
    Figure 28. Germany Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Parkinson Disease Drug Market Size Share by Region (2017-2028)
    Figure 38. China Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Parkinson Disease Drug Market Size Share by Country (2017-2028)
    Figure 48. Mexico Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Parkinson Disease Drug Market Size Share by Country (2017-2028)
    Figure 54. Turkey Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Merck Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 58. Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 59. GSK Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 60. Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 61. Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 62. Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 63. Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 64. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 65. Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 66. Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 67. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 68. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 69. H.Lundbeck Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 70. Valeant Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 71. Apokyn Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 72. Orion Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 73. Stada Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 74. US WorldMeds Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 75. Bausch Health Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
Frequently Asked Questions
Parkinson Disease Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parkinson Disease Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parkinson Disease Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pipeline Security

Pipeline Security market is segmented by players, region (country), by Type and by Application. P ... Read More

Step Stools

Step Stools market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More